Specifications
| Pharmacopoeia | IH |
| ChemSpider ID | 189912 |
| Formula | C23H22F7N4O6P |
| Elimination Half-life | 9 to 13 Hours (aprepitant) |
| Form | Powder |
| Color | White |
Fosaprepitant is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved by the United States Food and Drug Administration on January 25, 2008 and by the European Medicines Agency on January 11 of the same year.
